GE HealthCare Technologies Inc. $GEHC Shares Sold by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,700 shares of the company’s stock after selling 300 shares during the period. Louisiana State Employees Retirement System’s holdings in GE HealthCare Technologies were worth $4,274,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in GEHC. N.E.W. Advisory Services LLC acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $25,000. Bogart Wealth LLC lifted its stake in shares of GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after purchasing an additional 247 shares during the period. Stonebridge Financial Group LLC lifted its stake in shares of GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock valued at $29,000 after purchasing an additional 222 shares during the period. Olde Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $35,000. Finally, Zions Bancorporation National Association UT acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $42,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $75.13 on Thursday. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The firm has a market capitalization of $34.30 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 2.85 and a beta of 1.13. The company has a fifty day simple moving average of $74.22 and a 200-day simple moving average of $72.47. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Wall Street Analyst Weigh In

Several brokerages recently commented on GEHC. Weiss Ratings reissued a “hold (c)” rating on shares of GE HealthCare Technologies in a report on Saturday, September 27th. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Finally, Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $85.78.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.